Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Valerie Greene
Path-27. Identifying the Genetic Signature of Response in a Phase Ii Study of Tumor Treating Fields in Recurrent Glioblastoma
Neuro-Oncology
Cancer Research
Oncology
Neurology
Related publications
Tumor Treating Fields in Combination With Paclitaxel in Recurrent Ovarian Carcinoma: Results of the INNOVATE Pilot Study
Gynecologic Oncology
Gynecology
Oncology
Obstetrics
PC3 - 179 Analysis of Glioblastoma Physical Characteristics in Patients Benefiting From Tumor Treating Electric Fields Therapy
Canadian Journal of Neurological Sciences
Medicine
Neurology
Bevacizumab and Fotemustine for Recurrent Glioblastoma: A Phase II Study of AINO (Italian Association of Neuro-Oncology)
Journal of Neuro-Oncology
Cancer Research
Oncology
Neurology
Angiotensinogen and HLA Class II Predict Bevacizumab Response in Recurrent Glioblastoma Patients
Molecular Oncology
Cancer Research
Medicine
Oncology
Genetics
Molecular Medicine
Effects of Tumor Treating Fields (TTFields) on Glioblastoma Cells Are Augmented by Mitotic Checkpoint Inhibition
Cell Death Discovery
Cancer Research
Molecular Neuroscience
Immunology
Cell Biology
Cellular
Biological Activity of Tumor-Treating Fields in Preclinical Glioma Models
Cell Death and Disease
Molecular Neuroscience
Immunology
Cell Biology
Cancer Research
Cellular
Medicine
Genetic Basis of Radiation Response in Glioblastoma Multiforme
Nature Genetics
Genetics
Tumor Treating Fields for Glioblastoma Treatment: Patient Satisfaction and Compliance With the Second-Generation Optune® System
Clinical Medicine Insights: Oncology
Oncology
Response to Imatinib as a Function of Target Kinase Expression in Recurrent Glioblastoma
SpringerPlus
Multidisciplinary